Josh Clayton

Josh Clayton is passionate about all things related to cannabis, CBD and vapes. He has been covering news in this space for over 6 years, and he is always keeping an eye on the latest developments.

Philip Morris Drives Tobacco Industry’s Smoke-Free Pivot as ZYN and IQOS Reshape Global Nicotine Market

Philip Morris International has emerged as the dominant force in the global tobacco industry’s ongoing transformation away from combustible cigarettes, with its smoke-free product portfolio now accounting for more than 40 percent of total company revenue and its ZYN nicotine pouch brand commanding close to two thirds of the US oral nicotine market by value.

Philip Morris Drives Tobacco Industry’s Smoke-Free Pivot as ZYN and IQOS Reshape Global Nicotine Market Read More »

Republican Lawmakers Push Trump Administration to Treat Illegal Chinese Vapes as Trade Priority

More than 70 Republican members of the House of Representatives have urged the Trump administration to escalate its crackdown on illegal Chinese e-cigarettes by treating unauthorised vape imports as a formal priority in trade negotiations with Beijing, combining anti-China messaging with child-protection concerns ahead of the 2026 midterm elections. Lawmakers described the influx of unapproved

Republican Lawmakers Push Trump Administration to Treat Illegal Chinese Vapes as Trade Priority Read More »

FDA Grants First-Ever Approval for Fruit-Flavoured E-Cigarettes in Historic US Vaping Policy Shift

The US Food and Drug Administration has authorised the marketing of fruit-flavoured electronic cigarettes for the first time in American regulatory history, marking a decisive policy reversal that follows reported direct pressure from President Donald Trump and months of lobbying by the vaping industry. The FDA announced the authorisation of fruit-flavoured electronic cigarettes intended for

FDA Grants First-Ever Approval for Fruit-Flavoured E-Cigarettes in Historic US Vaping Policy Shift Read More »

Federal Hemp Ban Looms as DOJ Marijuana Rescheduling Fails to Resolve CBD Industry Crisis

The legal crisis facing the US CBD industry has deepened following confirmation that the Department of Justice’s landmark move to reschedule medical marijuana will do nothing to resolve the separate federal restriction on hemp-derived products scheduled to take effect in November 2026. The DOJ released a final order on April 23, 2026, immediately rescheduling medical

Federal Hemp Ban Looms as DOJ Marijuana Rescheduling Fails to Resolve CBD Industry Crisis Read More »

cannabis terpene

US House Passes Farm Bill Separating Industrial Hemp From CBD Products in Major Regulatory Overhaul

The United States House of Representatives has passed the Farm, Food, and National Security Act of 2026, a sweeping agriculture bill that formally separates industrial hemp from cannabinoid-linked crops for the first time in American regulatory history, drawing a clearer line between hemp grown for fibre and grain and hemp cultivated for CBD and related

US House Passes Farm Bill Separating Industrial Hemp From CBD Products in Major Regulatory Overhaul Read More »

Trump Pushes Congress to Save CBD Industry Before November Ban Takes Effect

President Donald Trump has called on Congress to act urgently to prevent a federal ban from effectively wiping out approximately 95 percent of the United States CBD and hemp product market, warning that millions of Americans who rely on full spectrum cannabidiol products could be left without access if lawmakers do not move before the

Trump Pushes Congress to Save CBD Industry Before November Ban Takes Effect Read More »

Scroll to Top